KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Zimmer Biomet Holdings (ZBH) Equity Average (2016 - 2026)

Zimmer Biomet Holdings has reported Equity Average over the past 18 years, most recently at $12.7 billion for Q1 2026.

  • For Q1 2026, Equity Average rose 2.04% year-over-year to $12.7 billion; the TTM value through Mar 2026 reached $12.7 billion, up 2.04%, while the annual FY2025 figure was $12.6 billion, 0.87% up from the prior year.
  • Equity Average for Q1 2026 was $12.7 billion at Zimmer Biomet Holdings, roughly flat from $12.7 billion in the prior quarter.
  • Over five years, Equity Average peaked at $12.7 billion in Q4 2025 and troughed at $12.1 billion in Q2 2022.
  • A 5-year average of $12.4 billion and a median of $12.4 billion in 2023 define the central range for Equity Average.
  • Biggest five-year swings in Equity Average: fell 4.34% in 2022 and later grew 3.76% in 2024.
  • Year by year, Equity Average stood at $12.1 billion in 2022, then increased by 3.0% to $12.5 billion in 2023, then decreased by 0.59% to $12.4 billion in 2024, then increased by 2.43% to $12.7 billion in 2025, then fell by 0.29% to $12.7 billion in 2026.
  • Business Quant data shows Equity Average for ZBH at $12.7 billion in Q1 2026, $12.7 billion in Q4 2025, and $12.6 billion in Q3 2025.